查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
吸入膠囊的全球市場規模、佔有率和趨勢分析：按類型、應用和地區分類的展望和預測（2024-2031）
市場調查報告書
商品編碼
1472510

吸入膠囊的全球市場規模、佔有率和趨勢分析：按類型、應用和地區分類的展望和預測（2024-2031）

Global Inhalation Capsules Market Size, Share & Trends Analysis Report By Type (Gelatin Capsules, and Hypromellose Capsules), By Application (Asthma Treatment, COPD Management, and Others), By Regional Outlook and Forecast, 2024 - 2031
出版日期: | 出版商: KBV Research | 英文 182 Pages | 訂單完成後即時交付

價格

預計到 2031 年，全球吸入膠囊市場規模將達到 14 億美元，預測期內年複合成長率為 5.9%。

此外，隨著醫療基礎設施的改善和醫療服務機會的增加，對呼吸系統疾病有效、便利的治療方案的需求增加，導致對吸入膠囊的需求增加。例如，在醫療保健產業快速擴張的中國和印度等國家，由於空氣污染和吸菸等因素，呼吸道疾病的盛行率大幅上升。因此，全球醫療保健產業的大幅擴張為市場成長創造了有利的環境。

然而，雖然吸入膠囊將藥物直接輸送到肺部，但一些藥物可能會進入血液並引起全身副作用。這些副作用包括心血管影響、血壓變化和代謝參數變化。患者和醫療保健專業人員可能擔心與吸入療法相關的全身副作用的可能性，特別是長期或高劑量使用時。因此，這些因素可能會阻礙市場的成長。

此外，COVID-19 大流行正在再形成需求動態、供應鏈以及醫療保健的提供方式。大流行期間人們對呼吸系統健康的日益關注，以及尋求治療氣喘和慢性阻塞性肺病等呼吸系統疾病的患者數量不斷增加，增加了對吸入膠囊藥物的需求。因此，疫情對市場整體有正面影響。

目錄

第1章 市場範圍與調查方法

  • 市場定義
  • 目的
  • 市場範圍
  • 分割
  • 調查方法

第2章 市集名錄

  • 主要亮點

第3章市場概況

  • 介紹
    • 概述
      • 市場構成和情景
  • 影響市場的主要因素
    • 市場促進因素
    • 市場限制因素
    • 市場機會
    • 市場挑戰
  • 波特五力分析

第4章吸入膠囊市場近期部署策略

第5章全球吸入膠囊市場：依類型

  • 全球明膠膠囊市場：按地區
  • 全球羥丙甲纖維素膠囊市場：按地區

第6章全球吸入膠囊市場：依應用分類

  • 全球氣喘治療市場：按地區
  • 全球慢性阻塞性肺病管理市場：按地區
  • 世界其他市場：按地區

第7章全球吸入膠囊市場：按地區

  • 北美洲
    • 北美吸入膠囊市場：依國家分類
      • 美國
      • 加拿大
      • 墨西哥
      • 北美其他地區
  • 歐洲
    • 歐洲吸入膠囊市場：依國家分類
      • 德國
      • 英國
      • 法國
      • 俄羅斯
      • 西班牙
      • 義大利
      • 其他歐洲國家
  • 亞太地區
    • 亞太地區吸入膠囊市場：依國家分類
      • 中國
      • 日本
      • 印度
      • 韓國
      • 澳洲
      • 馬來西亞
      • 其他亞太地區
  • 拉丁美洲/中東/非洲
    • 拉丁美洲/中東/非洲吸入膠囊市場（按國家）
      • 巴西
      • 阿根廷
      • 阿拉伯聯合大公國
      • 沙烏地阿拉伯
      • 南非
      • 奈及利亞
      • 其他拉丁美洲/中東/非洲

第8章 公司簡介

  • Cipla Limited
  • Novartis AG
  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • Lonza Group Ltd（Capsugel）
  • Chiesi Farmaceutici Sp.A
  • Vectura Group plc（Philip Morris International, Inc）
  • Elpen SA
  • Healthcaps India Ltd
  • Qualicaps Co, LTD.（Roquette Freres SA）

第9章 吸入膠囊市場成功的必要條件

The Global Inhalation Capsules Market size is expected to reach $1.4 billion by 2031, rising at a market growth of 5.9% CAGR during the forecast period.

Several factors contribute to the high prevalence of asthma in the U.S., including air pollution, allergens, tobacco smoke, and obesity. Urban areas, particularly in the Northeast and Midwest, have higher asthma rates due to higher air pollution and allergens. Consequently, the North America region generated USD 312.7 million revenue of the market in 2023. Moreover, the region has high healthcare spending, allowing patients better access to advanced treatment options, including inhalation capsules.

Technological advancements have resulted in the development of inhalation devices that are easier to use and more intuitive for patients. Features such as one-click mechanisms, ergonomic designs, and simplified instructions make inhalation devices more user-friendly, improving patient adherence and satisfaction. Advanced inhalation devices incorporate mechanisms to ensure precise and consistent medication dosing. Therefore, as these technological advancements evolve, the market is expected to expand further.

Additionally, as healthcare infrastructure improves and access to medical services increases, a growing demand for effective and convenient treatment options for respiratory diseases drives the demand for inhalation capsules. For example, in countries like China and India, where the healthcare industry is rapidly expanding, there is a significant increase in the prevalence of respiratory diseases due to factors such as air pollution and smoking. Hence, the substantial expansion of the healthcare industry globally has created a conducive environment for the growth of the market.

However, Inhalation capsules deliver medication directly to the lungs, but some amount of the drug may enter the bloodstream and cause systemic side effects. These side effects can include cardiovascular effects, changes in blood pressure, or alterations in metabolic parameters. Particularly with prolonged use or high doses, patients and medical professionals may be concerned about the potential for systemic adverse effects associated with inhalation therapies. Hence, these factors may hamper the market's growth.

Furthermore, the COVID-19 pandemic reshaping demand dynamics, supply chains, and healthcare delivery methods. With the heightened focus on respiratory health during the pandemic, there was an increased demand for medications delivered via inhalation capsules, driven by patients seeking to manage respiratory conditions such as asthma and COPD. Thus, the pandemic had an overall positive impact on the market.

By Type Analysis

Based on type, the market is characterized by gelatin capsules and hypromellose capsules. In 2023, the hypromellose capsules segment recorded a 38.2% revenue share in the market. Hypromellose capsules, also known as hydroxypropyl methylcellulose (HPMC) capsules, are gaining within the market. HPMC capsules offer several key benefits that make them well-suited for inhalation therapy. This versatility enables pharmaceutical companies to develop inhalation capsules containing various active pharmaceutical ingredients, catering to the specific needs of patients with different respiratory conditions.

By Application Analysis

On the basis of application, the market is classified into asthma treatment, COPD management, and others. The asthma treatment segment procured 48.5% revenue share in the market in 2023. Asthma treatment within the market encompasses a wide range of medications and delivery devices tailored to manage the symptoms and underlying inflammation associated with this chronic respiratory condition. Inhalation therapy is considered the cornerstone of asthma management because it delivers medications directly to the lungs, resulting in rapid onset of action, targeted treatment, and reduced systemic side effects.

By Regional Analysis

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Europe region held a 29.3% revenue share in the market in 2023. Europe is a leader in healthcare technology, leading to the development of advanced inhalation devices and formulations that drive market growth. Patients and healthcare professionals alike are well-informed regarding the advantages of inhalation therapy, which is propelling market expansion. Moreover, Europe has a favorable regulatory environment for developing and commercializing inhalation capsules, encouraging market growth.

Recent Strategies Deployed in the Market

  • Mar-2024: AstraZeneca Pharma India Limited, a subsidiary of AstraZeneca PLC, signed an agreement with Mankind Pharma Limited, a pharmaceutical company. Under this agreement, Mankind Pharma will exclusively distribute budesonide and formoterol fumarate dihydrate (inhaled corticosteroid (ICS) and long-acting beta-agonist (LABA) combination) brand Symbicort in India.
  • Dec-2023: AstraZeneca PLC got approval for its inhalation aerosol from the Central Drugs Standard Control Organisation (CDSCO). The inhalation aerosol consists of a triple combination of budesonide (160 mcg), glycopyrrolate (9 mcg), and formoterol fumarate (4.8 mcg) and is prescribed for the treatment and maintenance of patients with chronic obstructive pulmonary disease (COPD).
  • May-2021: Vectura Group Plc expanded its dry powder inhaler (DPI) development and manufacturing capabilities at its facility in Chippenham, U.K. Through this expansion, the company aims to facilitate integration with capsule inhaler devices, such as Vectura's open inhale close (OIC) device and the lever-operated multi-dose inhaler (LOMI) device utilized in Hikma's generic Advair product.
  • Mar-2021: Chiesi USA, Inc., a subsidiary of Chiesi Farmaceutici S.p.A., unveiled its bronchitol (mannitol) inhalation powder. The product is a dry powder-inhaled mucoactive agent that is compact, discrete, and portable and does not necessitate any nebulization, refrigeration, or routine cleaning.
  • Nov-2020: Chiesi Farmaceutici S.p.A. came into a partnership with Kaia Health Software GmbH, a digital therapeutics company. Under this partnership, the companies will market the Kaia Health Chronic Obstructive Pulmonary Disease (COPD) Pulmonary Rehabilitation app across Europe. Additionally, the partnership aims to provide patients with a digital therapeutic tool that facilitates COPD treatment outcomes by fostering behaviour change.

List of Key Companies Profiled

  • Cipla Limited
  • Novartis AG
  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • Lonza Group Ltd. (Capsugel)
  • Chiesi Farmaceutici S.p.A
  • Vectura Group Plc (Philip Morris International, Inc.)
  • Elpen S.A.
  • Healthcaps India Ltd.
  • Qualicaps Co., LTD. (Roquette Freres SA)

Global Inhalation Capsules Market Report Segmentation

By Type

  • Gelatin Capsules
  • Hypromellose Capsules

By Application

  • Asthma Treatment
  • COPD Management
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Table of Contents

Chapter 1.Market Scope & Methodology

  • 1.1Market Definition
  • 1.2Objectives
  • 1.3Market Scope
  • 1.4Segmentation
    • 1.4.1Global Inhalation Capsules Market, by Type
    • 1.4.2Global Inhalation Capsules Market, by Application
    • 1.4.3Global Inhalation Capsules Market, by Geography
  • 1.5Methodology for the research

Chapter 2.Market at a Glance

  • 2.1Key Highlights

Chapter 3.Market Overview

  • 3.1Introduction
    • 3.1.1Overview
      • 3.1.1.1Market Composition and Scenario
  • 3.2Key Factors Impacting the Market
    • 3.2.1Market Drivers
    • 3.2.2Market Restraints
    • 3.2.3Market Opportunities
    • 3.2.4Market Challenges
  • 3.3Porter's Five Forces Analysis

Chapter 4.Recent Strategies Deployed in Inhalation Capsules Market

Chapter 5.Global Inhalation Capsules Market by Type

  • 5.1Global Gelatin Capsules Market by Region
  • 5.2Global Hypromellose Capsules Market by Region

Chapter 6.Global Inhalation Capsules Market by Application

  • 6.1Global Asthma Treatment Market by Region
  • 6.2Global COPD Management Market by Region
  • 6.3Global Others Market by Region

Chapter 7.Global Inhalation Capsules Market by Region

  • 7.1North America Inhalation Capsules Market
    • 7.1.1North America Inhalation Capsules Market by Type
      • 7.1.1.1North America Gelatin Capsules Market by Region
      • 7.1.1.2North America Hypromellose Capsules Market by Region
    • 7.1.2North America Inhalation Capsules Market by Application
      • 7.1.2.1North America Asthma Treatment Market by Country
      • 7.1.2.2North America COPD Management Market by Country
      • 7.1.2.3North America Others Market by Country
    • 7.1.3North America Inhalation Capsules Market by Country
      • 7.1.3.1US Inhalation Capsules Market
        • 7.1.3.1.1US Inhalation Capsules Market by Type
        • 7.1.3.1.2US Inhalation Capsules Market by Application
      • 7.1.3.2Canada Inhalation Capsules Market
        • 7.1.3.2.1Canada Inhalation Capsules Market by Type
        • 7.1.3.2.2Canada Inhalation Capsules Market by Application
      • 7.1.3.3Mexico Inhalation Capsules Market
        • 7.1.3.3.1Mexico Inhalation Capsules Market by Type
        • 7.1.3.3.2Mexico Inhalation Capsules Market by Application
      • 7.1.3.4Rest of North America Inhalation Capsules Market
        • 7.1.3.4.1Rest of North America Inhalation Capsules Market by Type
        • 7.1.3.4.2Rest of North America Inhalation Capsules Market by Application
  • 7.2Europe Inhalation Capsules Market
    • 7.2.1Europe Inhalation Capsules Market by Type
      • 7.2.1.1Europe Gelatin Capsules Market by Country
      • 7.2.1.2Europe Hypromellose Capsules Market by Country
    • 7.2.2Europe Inhalation Capsules Market by Application
      • 7.2.2.1Europe Asthma Treatment Market by Country
      • 7.2.2.2Europe COPD Management Market by Country
      • 7.2.2.3Europe Others Market by Country
    • 7.2.3Europe Inhalation Capsules Market by Country
      • 7.2.3.1Germany Inhalation Capsules Market
        • 7.2.3.1.1Germany Inhalation Capsules Market by Type
        • 7.2.3.1.2Germany Inhalation Capsules Market by Application
      • 7.2.3.2UK Inhalation Capsules Market
        • 7.2.3.2.1UK Inhalation Capsules Market by Type
        • 7.2.3.2.2UK Inhalation Capsules Market by Application
      • 7.2.3.3France Inhalation Capsules Market
        • 7.2.3.3.1France Inhalation Capsules Market by Type
        • 7.2.3.3.2France Inhalation Capsules Market by Application
      • 7.2.3.4Russia Inhalation Capsules Market
        • 7.2.3.4.1Russia Inhalation Capsules Market by Type
        • 7.2.3.4.2Russia Inhalation Capsules Market by Application
      • 7.2.3.5Spain Inhalation Capsules Market
        • 7.2.3.5.1Spain Inhalation Capsules Market by Type
        • 7.2.3.5.2Spain Inhalation Capsules Market by Application
      • 7.2.3.6Italy Inhalation Capsules Market
        • 7.2.3.6.1Italy Inhalation Capsules Market by Type
        • 7.2.3.6.2Italy Inhalation Capsules Market by Application
      • 7.2.3.7Rest of Europe Inhalation Capsules Market
        • 7.2.3.7.1Rest of Europe Inhalation Capsules Market by Type
        • 7.2.3.7.2Rest of Europe Inhalation Capsules Market by Application
  • 7.3Asia Pacific Inhalation Capsules Market
    • 7.3.1Asia Pacific Inhalation Capsules Market by Type
      • 7.3.1.1Asia Pacific Gelatin Capsules Market by Country
      • 7.3.1.2Asia Pacific Hypromellose Capsules Market by Country
    • 7.3.2Asia Pacific Inhalation Capsules Market by Application
      • 7.3.2.1Asia Pacific Asthma Treatment Market by Country
      • 7.3.2.2Asia Pacific COPD Management Market by Country
      • 7.3.2.3Asia Pacific Others Market by Country
    • 7.3.3Asia Pacific Inhalation Capsules Market by Country
      • 7.3.3.1China Inhalation Capsules Market
        • 7.3.3.1.1China Inhalation Capsules Market by Type
        • 7.3.3.1.2China Inhalation Capsules Market by Application
      • 7.3.3.2Japan Inhalation Capsules Market
        • 7.3.3.2.1Japan Inhalation Capsules Market by Type
        • 7.3.3.2.2Japan Inhalation Capsules Market by Application
      • 7.3.3.3India Inhalation Capsules Market
        • 7.3.3.3.1India Inhalation Capsules Market by Type
        • 7.3.3.3.2India Inhalation Capsules Market by Application
      • 7.3.3.4South Korea Inhalation Capsules Market
        • 7.3.3.4.1South Korea Inhalation Capsules Market by Type
        • 7.3.3.4.2South Korea Inhalation Capsules Market by Application
      • 7.3.3.5Australia Inhalation Capsules Market
        • 7.3.3.5.1Australia Inhalation Capsules Market by Type
        • 7.3.3.5.2Australia Inhalation Capsules Market by Application
      • 7.3.3.6Malaysia Inhalation Capsules Market
        • 7.3.3.6.1Malaysia Inhalation Capsules Market by Type
        • 7.3.3.6.2Malaysia Inhalation Capsules Market by Application
      • 7.3.3.7Rest of Asia Pacific Inhalation Capsules Market
        • 7.3.3.7.1Rest of Asia Pacific Inhalation Capsules Market by Type
        • 7.3.3.7.2Rest of Asia Pacific Inhalation Capsules Market by Application
  • 7.4LAMEA Inhalation Capsules Market
    • 7.4.1LAMEA Inhalation Capsules Market by Type
      • 7.4.1.1LAMEA Gelatin Capsules Market by Country
      • 7.4.1.2LAMEA Hypromellose Capsules Market by Country
    • 7.4.2LAMEA Inhalation Capsules Market by Application
      • 7.4.2.1LAMEA Asthma Treatment Market by Country
      • 7.4.2.2LAMEA COPD Management Market by Country
      • 7.4.2.3LAMEA Others Market by Country
    • 7.4.3LAMEA Inhalation Capsules Market by Country
      • 7.4.3.1Brazil Inhalation Capsules Market
        • 7.4.3.1.1Brazil Inhalation Capsules Market by Type
        • 7.4.3.1.2Brazil Inhalation Capsules Market by Application
      • 7.4.3.2Argentina Inhalation Capsules Market
        • 7.4.3.2.1Argentina Inhalation Capsules Market by Type
        • 7.4.3.2.2Argentina Inhalation Capsules Market by Application
      • 7.4.3.3UAE Inhalation Capsules Market
        • 7.4.3.3.1UAE Inhalation Capsules Market by Type
        • 7.4.3.3.2UAE Inhalation Capsules Market by Application
      • 7.4.3.4Saudi Arabia Inhalation Capsules Market
        • 7.4.3.4.1Saudi Arabia Inhalation Capsules Market by Type
        • 7.4.3.4.2Saudi Arabia Inhalation Capsules Market by Application
      • 7.4.3.5South Africa Inhalation Capsules Market
        • 7.4.3.5.1South Africa Inhalation Capsules Market by Type
        • 7.4.3.5.2South Africa Inhalation Capsules Market by Application
      • 7.4.3.6Nigeria Inhalation Capsules Market
        • 7.4.3.6.1Nigeria Inhalation Capsules Market by Type
        • 7.4.3.6.2Nigeria Inhalation Capsules Market by Application
      • 7.4.3.7Rest of LAMEA Inhalation Capsules Market
        • 7.4.3.7.1Rest of LAMEA Inhalation Capsules Market by Type
        • 7.4.3.7.2Rest of LAMEA Inhalation Capsules Market by Application

Chapter 8.Company Profiles

  • 8.1Cipla Limited
    • 8.1.1Company Overview
    • 8.1.2Financial Analysis
    • 8.1.3Segmental and Regional Analysis
    • 8.1.4Research & Development Expense
    • 8.1.5SWOT Analysis
  • 8.2Novartis AG
    • 8.2.1Company Overview
    • 8.2.2Financial Analysis
    • 8.2.3Segmental and Regional Analysis
    • 8.2.4Research & Development Expense
    • 8.2.5Recent strategies and developments:
      • 8.2.5.1Trials and Approvals:
    • 8.2.6SWOT Analysis
  • 8.3AstraZeneca PLC
    • 8.3.1Company Overview
    • 8.3.2Financial Analysis
    • 8.3.3Regional Analysis
    • 8.3.4Research & Development Expenses
    • 8.3.5Recent strategies and developments:
      • 8.3.5.1Partnerships, Collaborations, and Agreements:
      • 8.3.5.2Trials and Approvals:
    • 8.3.6SWOT Analysis
  • 8.4Boehringer Ingelheim International GmbH
    • 8.4.1Company Overview
    • 8.4.2Financial Analysis
    • 8.4.3Regional & Segmental Analysis
    • 8.4.4Research & Development Expenses
    • 8.4.5SWOT Analysis
  • 8.5Lonza Group Ltd. (Capsugel)
    • 8.5.1Company Overview
    • 8.5.2Financial Analysis
    • 8.5.3Segmental and Regional Analysis
    • 8.5.4Research & Development Expenses
    • 8.5.5SWOT Analysis
  • 8.6Chiesi Farmaceutici S.p.A
    • 8.6.1Company Overview
    • 8.6.2Recent strategies and developments:
      • 8.6.2.1Partnerships, Collaborations, and Agreements:
      • 8.6.2.2Product Launches and Product Expansions:
    • 8.6.3SWOT Analysis
  • 8.7Vectura Group plc (Philip Morris International, Inc.)
    • 8.7.1Company Overview
    • 8.7.2Financial Analysis
    • 8.7.3Regional Analysis
    • 8.7.4Research & Development Expenses
    • 8.7.5Recent strategies and developments:
      • 8.7.5.1Partnerships, Collaborations, and Agreements:
      • 8.7.5.2Geographical Expansions:
    • 8.7.6SWOT Analysis
  • 8.8Elpen S.A.
    • 8.8.1Company Overview
    • 8.8.2SWOT Analysis
  • 8.9Healthcaps India Ltd.
    • 8.9.1Company Overview
    • 8.9.2SWOT Analysis
  • 8.10.Qualicaps Co., LTD. (Roquette Freres SA)
    • 8.10.1Company Overview
    • 8.10.2SWOT Analysis

Chapter 9.Winning Imperatives of Inhalation Capsules Market

LIST OF TABLES

  • TABLE 1Global Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 2Global Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 3Global Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 4Global Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 5Global Gelatin Capsules Market by Region, 2020 - 2023, USD Million
  • TABLE 6Global Gelatin Capsules Market by Region, 2024 - 2031, USD Million
  • TABLE 7Global Hypromellose Capsules Market by Region, 2020 - 2023, USD Million
  • TABLE 8Global Hypromellose Capsules Market by Region, 2024 - 2031, USD Million
  • TABLE 9Global Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 10Global Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 11Global Asthma Treatment Market by Region, 2020 - 2023, USD Million
  • TABLE 12Global Asthma Treatment Market by Region, 2024 - 2031, USD Million
  • TABLE 13Global COPD Management Market by Region, 2020 - 2023, USD Million
  • TABLE 14Global COPD Management Market by Region, 2024 - 2031, USD Million
  • TABLE 15Global Others Market by Region, 2020 - 2023, USD Million
  • TABLE 16Global Others Market by Region, 2024 - 2031, USD Million
  • TABLE 17Global Inhalation Capsules Market by Region, 2020 - 2023, USD Million
  • TABLE 18Global Inhalation Capsules Market by Region, 2024 - 2031, USD Million
  • TABLE 19North America Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 20North America Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 21North America Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 22North America Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 23North America Gelatin Capsules Market by Region, 2020 - 2023, USD Million
  • TABLE 24North America Gelatin Capsules Market by Region, 2024 - 2031, USD Million
  • TABLE 25North America Hypromellose Capsules Market by Region, 2020 - 2023, USD Million
  • TABLE 26North America Hypromellose Capsules Market by Region, 2024 - 2031, USD Million
  • TABLE 27North America Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 28North America Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 29North America Asthma Treatment Market by Country, 2020 - 2023, USD Million
  • TABLE 30North America Asthma Treatment Market by Country, 2024 - 2031, USD Million
  • TABLE 31North America COPD Management Market by Country, 2020 - 2023, USD Million
  • TABLE 32North America COPD Management Market by Country, 2024 - 2031, USD Million
  • TABLE 33North America Others Market by Country, 2020 - 2023, USD Million
  • TABLE 34North America Others Market by Country, 2024 - 2031, USD Million
  • TABLE 35North America Inhalation Capsules Market by Country, 2020 - 2023, USD Million
  • TABLE 36North America Inhalation Capsules Market by Country, 2024 - 2031, USD Million
  • TABLE 37US Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 38US Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 39US Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 40US Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 41US Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 42US Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 43Canada Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 44Canada Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 45Canada Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 46Canada Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 47Canada Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 48Canada Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 49Mexico Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 50Mexico Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 51Mexico Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 52Mexico Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 53Mexico Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 54Mexico Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 55Rest of North America Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 56Rest of North America Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 57Rest of North America Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 58Rest of North America Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 59Rest of North America Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 60Rest of North America Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 61Europe Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 62Europe Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 63Europe Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 64Europe Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 65Europe Gelatin Capsules Market by Country, 2020 - 2023, USD Million
  • TABLE 66Europe Gelatin Capsules Market by Country, 2024 - 2031, USD Million
  • TABLE 67Europe Hypromellose Capsules Market by Country, 2020 - 2023, USD Million
  • TABLE 68Europe Hypromellose Capsules Market by Country, 2024 - 2031, USD Million
  • TABLE 69Europe Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 70Europe Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 71Europe Asthma Treatment Market by Country, 2020 - 2023, USD Million
  • TABLE 72Europe Asthma Treatment Market by Country, 2024 - 2031, USD Million
  • TABLE 73Europe COPD Management Market by Country, 2020 - 2023, USD Million
  • TABLE 74Europe COPD Management Market by Country, 2024 - 2031, USD Million
  • TABLE 75Europe Others Market by Country, 2020 - 2023, USD Million
  • TABLE 76Europe Others Market by Country, 2024 - 2031, USD Million
  • TABLE 77Europe Inhalation Capsules Market by Country, 2020 - 2023, USD Million
  • TABLE 78Europe Inhalation Capsules Market by Country, 2024 - 2031, USD Million
  • TABLE 79Germany Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 80Germany Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 81Germany Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 82Germany Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 83Germany Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 84Germany Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 85UK Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 86UK Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 87UK Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 88UK Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 89UK Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 90UK Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 91France Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 92France Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 93France Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 94France Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 95France Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 96France Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 97Russia Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 98Russia Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 99Russia Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 100Russia Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 101Russia Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 102Russia Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 103Spain Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 104Spain Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 105Spain Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 106Spain Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 107Spain Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 108Spain Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 109Italy Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 110Italy Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 111Italy Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 112Italy Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 113Italy Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 114Italy Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 115Rest of Europe Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 116Rest of Europe Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 117Rest of Europe Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 118Rest of Europe Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 119Rest of Europe Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 120Rest of Europe Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 121Asia Pacific Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 122Asia Pacific Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 123Asia Pacific Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 124Asia Pacific Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 125Asia Pacific Gelatin Capsules Market by Country, 2020 - 2023, USD Million
  • TABLE 126Asia Pacific Gelatin Capsules Market by Country, 2024 - 2031, USD Million
  • TABLE 127Asia Pacific Hypromellose Capsules Market by Country, 2020 - 2023, USD Million
  • TABLE 128Asia Pacific Hypromellose Capsules Market by Country, 2024 - 2031, USD Million
  • TABLE 129Asia Pacific Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 130Asia Pacific Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 131Asia Pacific Asthma Treatment Market by Country, 2020 - 2023, USD Million
  • TABLE 132Asia Pacific Asthma Treatment Market by Country, 2024 - 2031, USD Million
  • TABLE 133Asia Pacific COPD Management Market by Country, 2020 - 2023, USD Million
  • TABLE 134Asia Pacific COPD Management Market by Country, 2024 - 2031, USD Million
  • TABLE 135Asia Pacific Others Market by Country, 2020 - 2023, USD Million
  • TABLE 136Asia Pacific Others Market by Country, 2024 - 2031, USD Million
  • TABLE 137Asia Pacific Inhalation Capsules Market by Country, 2020 - 2023, USD Million
  • TABLE 138Asia Pacific Inhalation Capsules Market by Country, 2024 - 2031, USD Million
  • TABLE 139China Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 140China Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 141China Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 142China Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 143China Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 144China Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 145Japan Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 146Japan Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 147Japan Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 148Japan Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 149Japan Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 150Japan Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 151India Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 152India Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 153India Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 154India Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 155India Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 156India Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 157South Korea Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 158South Korea Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 159South Korea Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 160South Korea Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 161South Korea Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 162South Korea Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 163Australia Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 164Australia Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 165Australia Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 166Australia Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 167Australia Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 168Australia Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 169Malaysia Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 170Malaysia Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 171Malaysia Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 172Malaysia Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 173Malaysia Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 174Malaysia Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 175Rest of Asia Pacific Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 176Rest of Asia Pacific Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 177Rest of Asia Pacific Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 178Rest of Asia Pacific Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 179Rest of Asia Pacific Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 180Rest of Asia Pacific Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 181LAMEA Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 182LAMEA Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 183LAMEA Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 184LAMEA Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 185LAMEA Gelatin Capsules Market by Country, 2020 - 2023, USD Million
  • TABLE 186LAMEA Gelatin Capsules Market by Country, 2024 - 2031, USD Million
  • TABLE 187LAMEA Hypromellose Capsules Market by Country, 2020 - 2023, USD Million
  • TABLE 188LAMEA Hypromellose Capsules Market by Country, 2024 - 2031, USD Million
  • TABLE 189LAMEA Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 190LAMEA Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 191LAMEA Asthma Treatment Market by Country, 2020 - 2023, USD Million
  • TABLE 192LAMEA Asthma Treatment Market by Country, 2024 - 2031, USD Million
  • TABLE 193LAMEA COPD Management Market by Country, 2020 - 2023, USD Million
  • TABLE 194LAMEA COPD Management Market by Country, 2024 - 2031, USD Million
  • TABLE 195LAMEA Others Market by Country, 2020 - 2023, USD Million
  • TABLE 196LAMEA Others Market by Country, 2024 - 2031, USD Million
  • TABLE 197LAMEA Inhalation Capsules Market by Country, 2020 - 2023, USD Million
  • TABLE 198LAMEA Inhalation Capsules Market by Country, 2024 - 2031, USD Million
  • TABLE 199Brazil Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 200Brazil Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 201Brazil Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 202Brazil Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 203Brazil Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 204Brazil Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 205Argentina Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 206Argentina Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 207Argentina Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 208Argentina Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 209Argentina Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 210Argentina Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 211UAE Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 212UAE Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 213UAE Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 214UAE Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 215UAE Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 216UAE Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 217Saudi Arabia Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 218Saudi Arabia Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 219Saudi Arabia Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 220Saudi Arabia Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 221Saudi Arabia Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 222Saudi Arabia Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 223South Africa Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 224South Africa Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 225South Africa Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 226South Africa Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 227South Africa Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 228South Africa Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 229Nigeria Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 230Nigeria Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 231Nigeria Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 232Nigeria Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 233Nigeria Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 234Nigeria Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 235Rest of LAMEA Inhalation Capsules Market, 2020 - 2023, USD Million
  • TABLE 236Rest of LAMEA Inhalation Capsules Market, 2024 - 2031, USD Million
  • TABLE 237Rest of LAMEA Inhalation Capsules Market by Type, 2020 - 2023, USD Million
  • TABLE 238Rest of LAMEA Inhalation Capsules Market by Type, 2024 - 2031, USD Million
  • TABLE 239Rest of LAMEA Inhalation Capsules Market by Application, 2020 - 2023, USD Million
  • TABLE 240Rest of LAMEA Inhalation Capsules Market by Application, 2024 - 2031, USD Million
  • TABLE 241Key Information - Cipla Limited
  • TABLE 242Key Information - Novartis AG
  • TABLE 243Key Information - AstraZeneca PLC
  • TABLE 244Key Information - Boehringer Ingelheim International GmbH
  • TABLE 245Key Information -Lonza Group Ltd.
  • TABLE 246Key Information - Chiesi Farmaceutici S.p.A
  • TABLE 247Key Information - Vectura Group plc
  • TABLE 248Key Information - Elpen S.A.
  • TABLE 249Key Information - Healthcaps India Ltd.
  • TABLE 250Key Information - Qualicaps Co., LTD.